Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Unknown Primary × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 93 Carcinoma, Non-Small-Cell Lung 30 Carcinoma, Renal Cell 21 Prostatic Neoplasms 14 Neoplasm Metastasis 14 Brain Neoplasms 12 Neoplasms 11 Lung Neoplasms 11 Breast Neoplasms 11 Uveal Melanoma 9 Sarcoma 9 Pancreatic Neoplasms 9 Small Cell Lung Carcinoma 7 Urinary Bladder Neoplasms 6 Kidney Neoplasms 6 Carcinoma, Transitional Cell 6 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Skin Neoplasms 5 Ovarian Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Histiocytoma, Malignant Fibrous 4 Colonic Neoplasms 4 Urogenital Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Osteosarcoma 3

Interventions

Gemcitabine 8 Carboplatin 8 Paclitaxel 6 Capecitabine 4 Irinotecan 3 Bevacizumab 3 pembrolizumab 2 atezolizumab 2 Peripheral Blood Stem Cell Transplantation 2 Oxaliplatin 2 Filgrastim 2 Erlotinib Hydrochloride 2 Cisplatin 2 CP protocol 2 tegafur-gimeracil-oteracil 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 entrectinib 1 cobimetinib 1 belinostat 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Transurethral Resection of Prostate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04131621 2020-04-15

CheCUP

University Hospital Heidelberg

Phase 2 Unknown

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡